AI assistant
Sending…
DEXCOM INC — Director's Dealing 2026
Feb 26, 2026
30198_dirs_2026-02-26_c3b8e231-0fca-48cf-821c-073f8ca96af8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2026-02-26
Reporting Person: Osterloh Albert Frederick IV (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-26 | Common Stock | A | 7061 | — | Acquired | 7061 | Direct |
Footnotes
F1: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
More from DEXCOM INC
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17
Regulatory Filings
2026
Feb 12
Annual Report
2026
Feb 12
Director's Dealing
2026
Feb 2